The global Cell Line Development Serum Market is experiencing robust growth, driven by increasing demand for biopharmaceuticals, advancements in drug discovery, and rising investments in biotechnology research. The market size was valued at approximately US$ 1.16 billion in 2023 and is projected to reach US$ 2.00 billion by 2031, registering a CAGR of 7.0% during the forecast period from 2024...